Abstract 2209: Cellular characterization of chromatin state via high throughput ChIP assay
作者
Zirong Li,John M. Rosenfeld,Robert Kovelman
出处
期刊:Cancer Research [American Association for Cancer Research] 日期:2012-04-01卷期号:72 (8_Supplement): 2209-2209
标识
DOI:10.1158/1538-7445.am2012-2209
摘要
Abstract Expression of eukaryotic genes during development requires complex spatial-temporal regulation. This complex regulation is often achieved through the coordinated interaction of transcription regulatory elements in the promoters of the target genes. The identification and mapping of regulatory elements in genome scale is crucial to understand how gene expression is regulated. Chromatin immunoprecipitation is a standard method for assessing the occupancy of DNA binding proteins in vivo in their native chromatin context using antibodies. However, standard chromatin immunoprecipitation procedure is time consuming, labor intensive and not suited for analyzing many samples simultaneously. Recently, we have developed a simple high throughput chromatin immunoprecipitation protocol that utilizes high capacity protein A/G coated magnetic beads and 96 well plates. This protocol requires fewer steps and less hands-on time, has higher sensitivity and more reliable performance as compared to conventional approaches. The method is also compatible with multi-channel pipetting and liquid handling systems. We have successfully used this protocol to map various clinically relevant chromatin marks and controls across several cell types to quantitatively measure chromatin states. This analysis included a variety of marks corresponding to repressed, poised and active promoters, strong and weak enhancers, putative insulators, transcribed regions, as well as large-scale repressed and inactive domains. This study demonstrates the utility of this approach for the characterization of model cellular systems in perturbation studies with chemical probes. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2209. doi:1538-7445.AM2012-2209